Providing independent clinical excellence since 2005
The idea of predicting a heart attack may have once seemed like science fiction, but it is rapidly becoming a reality. With the advent of advanced imaging techniques and artificial intelligence, we are now able to detect the early signs of coronary heart disease and intervene before a heart attack occurs. This represents a major shift in the way we approach cardiovascular care, moving from a reactive model to a proactive one.
Is is increasingly obvious that not everyone with raised coronary inflammation and elevated risk of heart attack simply has a raised LDL Cholesterol- in fact there appears to be a mixed bag of risk factors associated with high coronary artery inflammation, including raised LDL, raised LP (a), raised Homocysteine, hypertension and dysregulated glucose. Our metabolic health assessment is therefore designed to offer a comprehensive dive into known contributory causes, the latest and most controversial of which is 'glucose dysregulation', the principle topic of this article.
For patients who have been diagnosed with an acute coronary syndrome, requiring bypass surgery or stent, or have CT Angiography and or raised FAI, the latest European and UK guidelines reflect the finding that there is no lower limit for LDL yet discovered, basically meaning the lower the better. These recommendations come after new trials with lower targets showed better outcomes. As a result, millions of people around the world need to be looking more carefully at whether they are taking sufficient medication to lower their LDL to these new targets, for the very best outcomes to be achieved.
Ultimately, the approach to cardiac CT screening is highly individualized, reflecting the diverse presentations and risk factors among patients. By employing a sophisticated pre-consultation process, cardiologists can tailor their assessment and management plans to best suit each patient's unique needs, enhancing the precision and effectiveness of cardiac care.
There are two main reasons left atrial thrombus forms then detaches to cause embolic stroke. The first is that during atrial fibrillation or flutter, a thrombus may develop in the left atrial appendage, which does not move as much as it does when in sinus rhythm. The likelihood of this occurring in any given year is low, correlated to the CHA2DS2-VASc score. The second reason is not related to CHA2DS2-VASc score
Statins are a mind boggling biological 'ruse'. When this medication is taken orally, it causes liver cells to become deficient in essential cholesterol, so they respond by increasing the number of cell surface LDL receptors, thereby enhancing their capacity to extract LDL particles from the blood, significantly lowering circulating LDL levels. Statins remain the most effective and well-known way that doctors can lower LDL levels to prevent or treat coronary heart disease.
Who are Caristo? Caristo is a commercial data processing company that uses their algorithms to quantity coronary inflammation from a contrast coronary CT angiogram. The company uses their proprietary software to define their CaRi Hearts score which, over and above […]
SCVC Offers and promotions listed by launch date 25/9/2024 £500 cashback scheme offered nationwide to the first 100 patients in the UK undergoing a Cardiac CT (CTCA) with CaRi Heartscore. This test, which comprises a contrast CT coronary angiogram and […]
In 2023 the leadership team at SCVC decided that with an estimated 25,000 patients registered since 2006, it was time for us to issue newsletters and notify GPs and patients about our educational webinar events.
Annual health screenings are a valuable investment in employee well-being, offering significant benefits for both employees and employers. The HMRC’s tax exemption makes these screenings financially attractive, allowing companies to offer meaningful health benefits cost-effectively. Advanced medical technologies, such as AI-driven CT scans, enhance early detection capabilities, providing further value.
Continuous glucose monitoring offers a valuable tool for anyone concerned with their long-term health, especially those with a family history of diabetes or other cardiovascular risk factors. Whether through self-monitoring or professional analysis such as our metabolic health assessment, CGMs can provide actionable insights that help individuals manage their glucose levels more effectively, ultimately contributing to a healthier, longer life. By understanding and managing your glucotype, optimising your diet and exercise, and taking steps to prevent prediabetes and diabetes, you can potentially avoid serious health conditions in the future.
While predicting a heart attack with absolute certainty may still be beyond our reach, the ability to identify patients at high risk is a significant step forward. The latest techniques used to find people at risk are summarised in a […]
This blog explores how individuals can conduct their own experiments to maintain a steady blood glucose and avoid potentially unhealthy glucose spikes above 7.8 mmol/L (140 mg/dL).
The CaRi Heart Score leverages artificial intelligence and advanced imaging techniques to provide a more comprehensive assessment of coronary inflammation, even before non calcified and calcified plaque becomes detectable on CT.
There is a wealth of evidence linking pre-diabetes, raised HbA1c, and full-blown type 2 diabetes to increasing cardiovascular risk. Lesser degrees of a pre diabetic metabolism could therefore have an important role in causing long-term atherosclerosis.
Whether you are diabetic or simply health-conscious, understanding how to interpret CGM data can significantly enhance your approach to diet and lifestyle management. By recognising your body's unique responses to different foods and activities, you can make informed decisions that promote better metabolic health and overall well-being.